Invesaro

Stocks BOX Financial statements

Financial statements

BOX INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BOX INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue3995066086967718749911,0381,0901,177
Cost of revenue112135174216225249253261228245
Gross profit286371435481546625738777862933
Research and development116137164200201219244249265295
Selling and marketing253303312318276299331349380404
General and administrative68.284.893.1103107135127129137151
Operating expenses437525569620584652701726782849
Operating income-151-154-134-139-37.6-27.636.850.879.683.2
Interest expense4.873.846.0810.7
Interest income5.918.723.724.7
Other non-operating income0.680.791.34-3.47-4.58-9.84-3.47-3.04-12.11.5
Pre-tax income-151-154-133-143-42.2-37.534.462.685.298.7
Income tax0.910.721.41.411.2147.62-66.4-159-16.7
Net income-152-155-135-144-43.4-41.526.8129245115
EBITDA-111-114-87.9-8037.850.6103102102116
EPS, basic-1.19-1.16-0.95-0.98-0.28-0.350.060.691.400.60
EPS, diluted-1.19-1.16-0.95-0.98-0.28-0.350.060.671.360.58
Shares, basic (weighted)1271341411480.16156144144144144
Shares, diluted (weighted)1271341411480.16156150149149149

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents177208218196595416428384625375
Short-term investments0017032.896.998.2103
Receivables120162175209228256265281293325
Other current assets1.572.93.244.253.44283334.236.342
Total current assets3223994294588799178078421,098891
Property, plant and equipment1171241381911601067031.42523.8
Lease right-of-use assets19819417313199.47897.6
Goodwill16.316.318.718.718.774.573.976.87782.3
Intangible assets0.540.02017.739.246.874.594.3
Other non-current assets10.85.4113232.849.553.483.77.1296.6
Total assets4945546509601,3521,3921,2071,2411,6681,546
Accounts payable6.661715.416.84.55
Accrued liabilities30.437.734.532.539.154.744.136.949.757.8
Deferred revenue229292354407444519544563588648
Short-term debt02040
Total current liabilities298394463577613719716679922803
Long-term debt40404040298367369371449451
Lease liabilities20619316811894.268.877
Other non-current liabilities1.772.7549.514.315.644.637.835.930.818.3
Total liabilities4195396199381,2011,2991,2411,1801,4701,349
Total debt40404040298367369371653451
Paid-in capital9601,0551,1661,3021,474972819785677548
Retained earnings-884-1,039-1,134-1,278-1,322-1,363-1,336-1,207-962-847
Treasury stock-1.18-1.18-1.18-1.18-1.18
Other comprehensive income-0.120.290.02-0.31-0.94-4.54-7.07-9.69-11.9-0.14
Shareholders' equity74.71531.422.4151-395-524-431-297-299
Total equity74.71531.422.4151-395-524-431-297-299
Total liabilities and equity4945546509601,3521,3921,2071,2411,6681,546
Shares outstanding144151160145144144144141

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income-152-155-135-144-43.4-41.526.8129245115
Depreciation and amortization40.240.146.359.475.578.26651.222.132.9
Stock-based compensation78.497.5119146154179186199219234
Deferred income tax-0-0.36-0.65-0.27-0.35-1.911.65-75.3-171-31.5
Change in receivables-20.6-42-12.4-34.3-18.9-27.2-8.93-21.9-14.5-31.2
Change in payables-1.096.91.66-0.1-12.3
Cash from operations-2.3935.455.344.7197235298319332356
Capital expenditures-15-11.8-14.8-5.45-5.03-4.7-2.57-6.07
Acquisitions-0.46-59.4-2.73
Purchases of investments-170-102-169-121-104
Sales and maturities of investments7.06
Cash from investing-7.57-11.7-16.2-13.3-16.4-239121-82.8-23.2-42.7
Debt issued30
Stock issued15.717.521.929.428.925.424.526.925.927.2
Share buybacks-562-274-177-211-290
Cash from financing0.48-19.8-29.6-53.4219-173-396-273-62.4-570
Net change in cash-9.524.259.33-22.2400-17912.2-44.8242-249
Free cash flow-17.323.640.539.3293314330350
Interest paid1.241.942.595.557.484.692.751.68
Income taxes paid0.241.261.62.841.472.017.048.513.612.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $31.34 on September 28, 2026.

Profitability

MetricValueHow it is calculated
Gross margin79.5%Gross profit / revenue.
Operating margin9.4%Operating income / revenue.
EBITDA margin12.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin9.8%Pre-tax income / revenue.
Net margin10.6%Net income / revenue.
FCF margin31.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin32.0%Cash from operations / revenue.
Effective tax rate-7.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)9.3%Net income / average total assets.
R&D / revenue24.7%Research and development expense / revenue.
Stock-based pay / revenue19.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.4%Capital expenditures / revenue.
D&A / revenue3.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y8.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y5.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y8.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y8.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y8.1%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y11.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y4.5%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y31.2%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y14.1%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y4.1%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y25.1%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-52.8%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y62.7%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y-57.4%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y113.0%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y7.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y6.2%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y12.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y6.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y6.1%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y-7.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y8.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y2.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y294.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.06xCurrent assets / current liabilities.
Quick ratio0.92x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.62x(Cash + short-term investments) / current liabilities.
Debt / assets32.2%Total debt / total assets.
Liabilities / assets89.6%Total liabilities / total assets.
Net debt$8.1MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.05xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage11.5xOperating income / interest expense.
Working capital$42.1MCurrent assets - current liabilities.
Goodwill and intangibles / assets13.1%(Goodwill + intangible assets) / total assets.
Tangible book value-$535.5MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.88xRevenue / average total assets.
Receivables turnover5.78xRevenue / average receivables.
Days sales outstanding63 days365 x average receivables / revenue.
FCF conversion297.8%Free cash flow / net income, when net income is positive.
Capex / operating cash flow1.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.94Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$8.83Revenue / diluted weighted shares.
FCF per share$2.79Free cash flow / diluted weighted shares.
Operating cash flow per share$2.82Cash from operations / diluted weighted shares.
Book value per share-$2.56Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$3.90Tangible book value / shares outstanding.
Cash per share$3.24(Cash + short-term investments) / shares outstanding.
Buybacks / FCF99.2%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$4.34BShare price x shares outstanding.
Enterprise value$4.35BMarket cap + total debt - cash - short-term investments.
P/E33.2xMarket cap / net income. Only when net income is positive.
P/S3.52xMarket cap / revenue.
P/FCF11.1xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF11.0xMarket cap / cash from operations, when positive.
EV/Sales3.52xEnterprise value / revenue.
EV/EBIT37.4xEnterprise value / operating income, when both are positive.
EV/EBITDA28.3xEnterprise value / EBITDA, when both are positive.
EV/FCF11.2xEnterprise value / free cash flow, when both are positive.
FCF yield9.0%Free cash flow / market cap.
Earnings yield3.0%Net income / market cap (the inverse of P/E).
Shareholder yield8.9%(Dividends paid + share buybacks) / market cap.
PEG0.29xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was BOX INC's revenue in fiscal 2026?

BOX INC reported revenue of $1.18B for fiscal 2026, 8% higher than the year before.

Was BOX INC profitable in fiscal 2026?

Yes. Net income was $115.4M, a net margin of 9.8%.

How much free cash flow did BOX INC generate in fiscal 2026?

Cash from operations of $356.5M minus capital expenditures of $6.1M left free cash flow of $350.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BOX INC